Emplicure AB Interim Report Q1 2023

MAR

FIRST QUARTER, JANUARY-MARCH 2023

  • Net sales amounted to MSEK 0.0 (0.0)
  • Operating loss (EBIT) amounted to MSEK -6.3 (-7.3)
  • Net loss amounted to MSEK -6.8 (-7.3)
  • Net cash flow amounted to MSEK -6.0 (-5.6)
  • EPS before and after dilution amounted to SEK -0.26 (-0.36)

 

From this report and onwards, Emplicure will present the quarterly financial reports in English only.

This information is information that Emplicure AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons above, on May 9, 2023 at 07:58 CET

For additional information, please contact

Håkan Engqvist

CEO
Phone: +46 702 569 500
Email: hakan.engqvist@emplicure.com

Erik Magnusson

CFO
Phone: +46 708 565 245
Email: erik.magnusson@emplicure.com

Certified Adviser

Emplicure AB (publ) is listed on the Nasdaq First North Growth Market. Certified Adviser is Erik Penser Bank.

Emplicure develops new and innovative products by combining existing and approved active substances with advanced materials science within ceramic biomaterials. The product portfolio is focused on chronic pain and on abuse-deterrent formulations. The subsidiary Amplicon AB develops consumer products with oral nicotine as the first product. The share is listed on Nasdaq First North Growth Market (EMPLI). Read more at www.emplicure.com

Datum 2023-05-09, kl 07:58
Källa beQuoted
Skapa konto direkt med BankID hos Skilling så får du tillgång till tusentals finansmarknader inom valuta, aktier, krypto och mycket mer. Välj bland 1200+ CFD-instrument över 7 tillgångsklasser till konkurrenskraftiga priser. Skilling erbjuder också en kapitalförsäkring.
CFD är komplexa instrument och har en hög risk att förlora pengar snabbt på grund av hävstång. 77% av icke-professionella kunder förlorar pengar när de handlar med CFD med denna leverantör.